HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leila Antonangelo Selected Research

Fibrosis (Cirrhosis)

11/2023COVID-19 induces more pronounced extracellular matrix deposition than other causes of ARDS.
10/2012Monoclonal antibodies anti-TGFβ1 and anti-VEGF inhibit the experimental pleurodesis induced by silver nitrate.
8/2009Low doses of silver nitrate induce pleurodesis with a limited systemic response.
4/2009Influence of parecoxib (cox-2 inhibitor) in experimental pleurodesis.
9/2007Transforming growth factor beta-1 as a predictor of fibrosis in tuberculous pleurisy.
7/2007Pleurodesis: a novel experimental model.
3/2006Pleurodesis induced by talc or silver nitrate: evaluation of collagen and elastic fibers in pleural remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leila Antonangelo Research Topics

Disease

12Inflammation (Inflammations)
07/2018 - 06/2004
10COVID-19
11/2023 - 01/2021
9Pleural Effusion (Pleural Effusions)
01/2019 - 07/2006
7Fibrosis (Cirrhosis)
11/2023 - 03/2006
6Malignant Pleural Effusion
01/2016 - 08/2005
5Rheumatic Diseases (Rheumatism)
12/2022 - 10/2021
5Tuberculosis (Tuberculoses)
11/2012 - 09/2007
4Neoplasms (Cancer)
01/2016 - 01/2004
3Pleural Tuberculosis
11/2012 - 07/2006
2Asthma (Bronchial Asthma)
12/2022 - 01/2018
2Visceral Leishmaniasis (Kala Azar)
06/2021 - 01/2021
2Lymphopenia (Lymphocytopenia)
01/2021 - 01/2021
2Pneumonia (Pneumonitis)
07/2018 - 04/2009
2Edema (Dropsy)
01/2018 - 12/2002
2Lymphoma (Lymphomas)
01/2016 - 03/2012
2Pain (Aches)
04/2009 - 08/2005
1Sepsis (Septicemia)
10/2023
1Myocarditis (Carditis)
10/2023
1Segmental glomerulosclerosis
12/2022
1Membranous Glomerulonephritis (Membranous Nephropathy)
12/2022
1Vasculitis (Vasculitides)
01/2022
1Human Influenza (Influenza)
10/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2021
1Leishmaniasis
06/2021
1Infections
01/2021
1Pharyngitis (Sore Throat)
01/2021
1Hypotension (Low Blood Pressure)
01/2021
1Shock
01/2021
1Anemia
01/2021
1Nausea
01/2021
1Type 2 Diabetes Mellitus (MODY)
04/2019
1Insulin Resistance
04/2019
1Obesity
04/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2018

Drug/Important Bio-Agent (IBA)

7Adenosine DeaminaseIBA
01/2019 - 07/2006
7TalcFDA Link
11/2009 - 12/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016 - 12/2007
5CollagenIBA
11/2023 - 03/2006
5Proteins (Proteins, Gene)FDA Link
10/2023 - 10/2007
5Silver NitrateIBA
11/2009 - 08/2005
4CytokinesIBA
11/2023 - 01/2012
4Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2018
4sinovac COVID-19 vaccineIBA
12/2022 - 10/2021
3VaccinesIBA
10/2023 - 10/2021
3Immunoglobulin G (IgG)IBA
12/2022 - 01/2022
3COVID-19 VaccinesIBA
12/2022 - 01/2022
3Cholecalciferol (Vitamin D3)FDA Link
01/2022 - 01/2021
3Interleukin-8 (Interleukin 8)IBA
11/2012 - 06/2004
2Interferon-gamma (Interferon, gamma)IBA
10/2023 - 01/2019
2Inactivated VaccinesIBA
12/2022 - 10/2021
2amsonic acid (DAS)IBA
02/2022 - 03/2012
2Vitamin DFDA LinkGeneric
01/2022 - 01/2021
225-hydroxyvitamin DIBA
01/2021 - 01/2021
2BiofuelsIBA
07/2018 - 07/2010
1Versicans (Versican)IBA
11/2023
1Fibronectins (Fibronectin)IBA
11/2023
1DecorinIBA
11/2023
1Neutralizing AntibodiesIBA
12/2022
1Messenger RNA (mRNA)IBA
12/2022
1BNT162 VaccineIBA
12/2022
1AntibodiesIBA
12/2022
1Phospholipases A2 (Phospholipase A2)IBA
12/2022
1AntigensIBA
12/2022
1ThrombospondinsIBA
12/2022
1Attenuated VaccinesIBA
04/2022
1Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link
04/2022
1PropiolactoneFDA Link
02/2022
1Prednisone (Sone)FDA LinkGeneric
01/2022
1ChemokinesIBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1LipidsIBA
06/2021
1Lipid NanoparticlesIBA
06/2021
1Ursolic AcidIBA
06/2021
1TriterpenesIBA
01/2021
1ORALIT (ORS)IBA
01/2021
1Pentacyclic TriterpenesIBA
01/2021
1L 35 (L35)IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1hydroxide ionIBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2021
1Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
04/2019
1GlycogenIBA
04/2019
1IncretinsIBA
04/2019
1Interleukin-27 (Interleukin 27)IBA
01/2019
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
07/2018
1Endothelins (Endothelin)IBA
07/2018
1IsoprostanesIBA
07/2018
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2018

Therapy/Procedure

12Pleurodesis
01/2016 - 12/2002
3Length of Stay
01/2021 - 01/2021
2Therapeutics
01/2018 - 09/2015
2Drug Therapy (Chemotherapy)
09/2010 - 12/2007
1Artificial Respiration (Mechanical Ventilation)
11/2023
1Critical Care (Surgical Intensive Care)
01/2023
1Intramuscular Injections
02/2022
1Gastrostomy
04/2019
1Gastric Bypass (Roux-en-Y Gastric Bypass)
04/2019
1Caloric Restriction
04/2019